Premium
Increased medial orbitofrontal [ 18 F]fluorodopa uptake in Parkinsonian impulse control disorders
Author(s) -
Joutsa Juho,
Martikainen Kirsti,
Niemelä Solja,
Johansson Jarkko,
Forsback Sarita,
Rinne Juha O.,
Kaasinen Valtteri
Publication year - 2012
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.24941
Subject(s) - monoaminergic , orbitofrontal cortex , hypersexuality , impulse control , medicine , dopamine , psychology , impulse control disorder , striatum , psychiatry , pathological , prefrontal cortex , cognition , serotonin , receptor , disease
Background: Impulse control disorders (ICDs) occur frequently in PD patients. Methods: To investigate the possible involvement of the mesostriatal and mesolimbic monoaminergic function in ICDs associated with PD, we examined patients with (n = 10) and without (n = 10) ICDs using the brain [ 18 F]fluorodopa PET. Results: Patients with ICDs (e.g., pathological gambling, hypersexuality, and compulsive eating) showed up to 35% higher [ 18 F]fluorodopa uptake in the medial orbitofrontal cortex, compared to control patients, but no differences in the striatum. The results remained significant also after excluding subjects with comorbid psychiatric disorders. Conclusions: Increased monoaminergic activity in the medial orbitofrontal cortex might be associated with increased sensitivity for ICDs under dopamine‐replacement therapy in PD. © 2012 Movement Disorder Society
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom